Crystal structures of the catalytic domain of human soluble guanylate cyclase.

Soluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous α and β subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the α and β su...

Full description

Saved in:
Bibliographic Details
Main Authors: Charles K Allerston, Frank von Delft, Opher Gileadi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0057644&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434204755984384
author Charles K Allerston
Frank von Delft
Opher Gileadi
author_facet Charles K Allerston
Frank von Delft
Opher Gileadi
author_sort Charles K Allerston
collection DOAJ
description Soluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous α and β subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the α and β subunits, as well as an inactive homodimer of β subunits. This first structure of a metazoan, heteromeric cyclase provides several observations. First, the structures resemble known structures of adenylate cyclases and other guanylate cyclases in overall fold and in the arrangement of conserved active-site residues, which are contributed by both subunits at the interface. Second, the subunit interaction surface is promiscuous, allowing both homodimeric and heteromeric association; the preference of the full-length enzyme for heterodimer formation must derive from the combined contribution of other interaction interfaces. Third, the heterodimeric structure is in an inactive conformation, but can be superposed onto an active conformation of adenylate cyclase by a structural transition involving a 26° rigid-body rotation of the α subunit. In the modelled active conformation, most active site residues in the subunit interface are precisely aligned with those of adenylate cyclase. Finally, the modelled active conformation also reveals a cavity related to the active site by pseudo-symmetry. The pseudosymmetric site lacks key active site residues, but may bind allosteric regulators in a manner analogous to the binding of forskolin to adenylate cyclase. This indicates the possibility of developing a new class of small-molecule modulators of guanylate cyclase activity targeting the catalytic domain.
format Article
id doaj-art-924c6287d2654f7db167714b32e9897c
institution Kabale University
issn 1932-6203
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-924c6287d2654f7db167714b32e9897c2025-08-20T03:26:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5764410.1371/journal.pone.0057644Crystal structures of the catalytic domain of human soluble guanylate cyclase.Charles K AllerstonFrank von DelftOpher GileadiSoluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous α and β subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the α and β subunits, as well as an inactive homodimer of β subunits. This first structure of a metazoan, heteromeric cyclase provides several observations. First, the structures resemble known structures of adenylate cyclases and other guanylate cyclases in overall fold and in the arrangement of conserved active-site residues, which are contributed by both subunits at the interface. Second, the subunit interaction surface is promiscuous, allowing both homodimeric and heteromeric association; the preference of the full-length enzyme for heterodimer formation must derive from the combined contribution of other interaction interfaces. Third, the heterodimeric structure is in an inactive conformation, but can be superposed onto an active conformation of adenylate cyclase by a structural transition involving a 26° rigid-body rotation of the α subunit. In the modelled active conformation, most active site residues in the subunit interface are precisely aligned with those of adenylate cyclase. Finally, the modelled active conformation also reveals a cavity related to the active site by pseudo-symmetry. The pseudosymmetric site lacks key active site residues, but may bind allosteric regulators in a manner analogous to the binding of forskolin to adenylate cyclase. This indicates the possibility of developing a new class of small-molecule modulators of guanylate cyclase activity targeting the catalytic domain.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0057644&type=printable
spellingShingle Charles K Allerston
Frank von Delft
Opher Gileadi
Crystal structures of the catalytic domain of human soluble guanylate cyclase.
PLoS ONE
title Crystal structures of the catalytic domain of human soluble guanylate cyclase.
title_full Crystal structures of the catalytic domain of human soluble guanylate cyclase.
title_fullStr Crystal structures of the catalytic domain of human soluble guanylate cyclase.
title_full_unstemmed Crystal structures of the catalytic domain of human soluble guanylate cyclase.
title_short Crystal structures of the catalytic domain of human soluble guanylate cyclase.
title_sort crystal structures of the catalytic domain of human soluble guanylate cyclase
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0057644&type=printable
work_keys_str_mv AT charleskallerston crystalstructuresofthecatalyticdomainofhumansolubleguanylatecyclase
AT frankvondelft crystalstructuresofthecatalyticdomainofhumansolubleguanylatecyclase
AT ophergileadi crystalstructuresofthecatalyticdomainofhumansolubleguanylatecyclase